Actuate Therapeutics, Inc. (ACTU)
0.3202
-0.01
(-2.08%)
USD |
NASDAQ |
Nov 06, 10:22
Actuate Therapeutics EPS Diluted (Quarterly) : -0.2039 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2039 |
| March 31, 2026 | -0.239 |
| December 31, 2025 | -0.1959 |
| September 30, 2025 | -0.2527 |
| June 30, 2025 | -0.3028 |
| March 31, 2025 | -0.324 |
| December 31, 2024 | -0.33 |
| Date | Value |
|---|---|
| September 30, 2024 | -0.3057 |
| June 30, 2024 | -0.3365 |
| March 31, 2024 | -0.4341 |
| December 31, 2023 | -0.3983 |
| September 30, 2023 | -0.3245 |
| June 30, 2023 | -0.2828 |
| March 31, 2023 | -0.2758 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 2.373 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.867M |
| Total Expenses (Quarterly) | 4.867M |
| Enterprise Value | 3.832M |
| Earnings Yield | -278.4% |
| Normalized Earnings Yield | -278.42 |